Diagnostics and preventive therapy of allergic rhinitis in children: modern algorithm
DOI: 10.32364/2618-8430-2023-6-3-11
P.V. Berezhanskiy1-4, A.B. Malakhov1,3,4, N.A. Geppe1, N.G. Kolosova1, N.S. Tataurshchikova2
1I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
2RUDN University, Moscow, Russian Federation
3Morozov Children's City Clinical Hospital, Moscow, Russian Federation
4Research Clinical Institute of Childhood of the Moscow Region, Moscow, Russian Federation
Background: allergic rhinitis (AR) is the leading pathology in pediatric practice. Improvement of the diagnostic accuracy and preventive measures in AR is the priority task.
Aim: to evaluate the efficacy of the proposed cascade algorithm of diagnosis and preventive medicated therapy for children at high risk of AR.
Patients and Methods: a retrospective epidemiological analysis was conducted in five regions of the Central Federal District for 2017–2021, where the main risk factors of AR were identified. The article proposes a screening cascade and a three-step diagnostic algorithm of AR, as well as high-risk group identification with the indication of preventive medicated therapy. The efficacy of the proposed technique was evaluated in the catamnestic study.
Results: during the follow-up, there was a steady increase of AR in all regions — from 1,472 to 2,684%. 28 risk factors were identified, of which 12 were controlled factors. According to the highest risk factor probability, 4 age groups were identified: from birth to 5 years, 6–7 years, 8–12 years and children 13 years and older. In the group receiving preventive therapy, AR was verified in the catamnesis 2 times less common — in 12 instead of 24%. Thus, the patients at high risk of AR require preventive medicated therapy and constant follow-up at certain age periods.
Conclusion: this article presents the evaluation of the proposed diagnostic cascade efficacy, the identification of the group at high risk of AR and the justification concerning the use of preventive medicated therapy of AR in this group during acute respiratory infection.
Keywords: allergic rhinitis, preventive therapy, polymorphism, heart rate variability, microcirculation.
For citation: Berezhanskiy P.V., Malakhov A.B., Geppe N.A., Kolosova N.G., Tataurshchikova N.S. Diagnostics and preventive therapy of allergic rhinitis in children: modern algorithm. Russian Journal of Woman and Child Health. 2023;6(3):276–282 (in Russ.). DOI: 10.32364/2618-8430-2023-6-3-11.
About the authors:
Pavel V. Berezhanskiy — C. Sc. (Med.), Associate Professor of the Department of Children's Diseases, N.F. Filatov Clinical Institute of Children's Health, I.M. Sechenov First Moscow State Medical University (Sechenov University); 8, Build. 2, Trubetskaya str., Moscow, 119991, Russian Federation; Assistant Professor of Clinical Immunology and Allergology, RUDN University; 6, Miklukho-Maklaya str., Moscow, 117198, Russian Federation; pulmonologist, Morozov Children's City Clinical Hospital; 1/9, 4th Dobryninskiy pass., Moscow, 119049, Russian Federation; Senior Researcher of the Department of Pediatrics, Research Clinical Institute of Childhood of the Moscow Region; 62, Bolshaya Serpukhovskaya str., Moscow, 115093, Russian Federation; ORCID iD 0000-0001-5235-5303.
Alexander B. Malakhov — Dr. Sc. (Med.), Professor of the Department of Children's Diseases, N.F. Filatov Clinical Institute of Children's Health, I.M. Sechenov First Moscow State Medical University (Sechenov University); 8, Build. 2, Trubetskaya str., Moscow, 119991, Russian Federation; Chief Consultant Children Pulmonologist, Morozov Children's City Clinical Hospital; 1/9, 4th Dobryninskiy pass., Moscow, 119049, Russian Federation; Head of the Department of Pediatrics, Research Clinical Institute of Childhood of the Moscow Region; 62, Bolshaya Serpukhovskaya str., Moscow, 115093, Russian Federation; ORCID iD 0000-0002-2686-8284.
Natalia A. Geppe — Dr. Sc. (Med), Professor, Honored Doctor of the Russian Federation, Head of the Department of Children's Diseases, N.F. Filatov Clinical Institute of Children's Health, I.M. Sechenov First Moscow State Medical University (Sechenov University); 8, Build. 2, Trubetskaya str., Moscow, 119991, Russian Federation; ORCID iD 0000-0003-0547-3686.
Natalia G. Kolosova — C. Sc. (Med.), Associate Professor of the Department of Children's Diseases, N.F. Filatov Clinical Institute of Children's Health, I.M. Sechenov First Moscow State Medical University (Sechenov University); 8, Build. 2, Trubetskaya str., Moscow, 119991, Russian Federation; ORCID iD 0000-0001-5071-9302.
Natalia S. Tataurshchikova — Dr. Sc. (Med.), Professor, Head of the Department of Clinical Immunology and Allergology, RUDN University; 6, Miklukho-Maklaya str., Moscow, 117198, Russian Federation; ORCID iD 0000-0002-3486-8188.
Contact information: Pavel V. Berezhanskiy, e-mail: p.berezhanskiy@mail.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 30.06.2023.
Revised 21.07.2023.
Accepted 11.08.2023.
2. Озерская И.В., Геппе Н.А., Малявина У.С. Особенности респираторного эпителия у детей с бронхиальной астмой и аллергическим ринитом. Доктор.Ру. 2018;11(155):50–56. DOI: 10.31550/1727-2378-2018-155-11-50-56. [Ozerskaya I.V., Geppe N.A., Malyavina U.S. Characteristic Features of the Respiratory Epithelium in Children with Asthma and Allergic Rhinitis. Doctor.Ru. 2018;11(155):50–56 (in Russ.)]. DOI: 10.31550/1727-2378-2018-155-11-50-56.
3. Bousquet J., Anto J.M., Bachert C. et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95. DOI: 10.1038/s41572-020-00227-0.
4. Ciofalo A., Pasquariello B., Iannella G. et al. The role of nasal cytology in the diagnosis of allergic and non-allergic rhinitisin adult and children. Eur Rev Med Pharmacol Sci. 2019;23(12):5065–5073. DOI: 10.26355/eurrev_201906_18170.
5. Геппе Н.А., Колосова Н.Г., Кондюрина Е.Г. и др. Современные международные и российские рекомендации по мониторированию и лечению бронхиальной астмы у детей. Педиатрия им. Г.Н. Сперанского. 2022;101(3):51–57. DOI: 10.24110/0031-403X-2022-101-3-51-57. [Geppe N.A., Kolosova N.G., Kondyurina E.G. et al. Modern international and Russian recommendations for monitoring and treatment of bronchial asthma in children. Pediatria n.a. G.N. Speransky. 2022;101(3):51–57 (in Russ.)]. DOI: 10.24110/0031-403X-2022-101-3-51-57.
6. Геппе Н.А., Мелешкина А.В., Чебышева С.Н., Великорецкая М.Д. Приоритеты в тактике ведения детей с бронхиальной обструкцией на фоне острой респираторной вирусной инфекции: что нового? Доктор.Ру. 2021;20(3):6–10. DOI: 10.31550/1727-2378-2021-20-3-6-10. [Geppe N.A., Meleshkina A.V., Chebysheva S.N., Velikoretskaya M.D. Priorities in the management of children with dronchial obstruction due to acute respiratory viral infection: what is new? Doctor.Ru. 2021;20(3):6–10 (in Russ.)]. DOI: 10.31550/1727-2378-2021-20-3-6-10.
7. Царев С.В. Инфекция и аллергия: взаимосвязь и взаимовлияние. РМЖ. 2016;12:800–803. [Tsarev S.V. Infection and allergy: relationship and mutual influence. RMJ. 2016;12:800–803 (in Russ.)].
8. Bousquet J., Schünemann H.J., Togias A. et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70–80.e3. DOI: 10.1016/j.jaci.2019.06.049.
9. Julian P.T., Altman D.G., Moheretal D. et al. The Cochrane Collaboration's tool for assessing riskof bias in randomised trial. BMJ. 2011;343:d5928. DOI: 10.1136/bmj.d5928.
10. Brożek J.L., Bousquet J., Agache I. et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. DOI: 10.1016/j.jaci.2017.03.050.
11. Wang J., Zhou Y., Zhang H. Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):138. DOI: 10.1038/s41392-023-01344-4.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
